|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
20
|
|
pubmed:dateCreated |
2010-7-9
|
|
pubmed:abstractText |
Treosulfan was introduced recently as a conditioning agent for allogeneic blood stem-cell transplantation. The favorable nonhematologic toxicity profile at 3 x 10 g/m(2) was the basis for dose escalation in this prospective, multicenter trial.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AschanJohanJ,
pubmed-author:BaumgartJoachimJ,
pubmed-author:BlauIgor WIW,
pubmed-author:CasperJochenJ,
pubmed-author:FreundMathiasM,
pubmed-author:GiebelSebastianS,
pubmed-author:HilgendorfInkenI,
pubmed-author:HolowieckiJerzyJ,
pubmed-author:KnaufWolfgangW,
pubmed-author:KrögerNicolausN,
pubmed-author:MyliusHeidrun AHA,
pubmed-author:PichlmeierUweU,
pubmed-author:RuutuTapaniT,
pubmed-author:Schäfer-EckartKerstinK,
pubmed-author:VolinLiisaL,
pubmed-author:WandtHannesH,
pubmed-author:WolffDanielD,
pubmed-author:ZanderAxel RAR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3344-51
|
|
pubmed:dateRevised |
2010-8-19
|
|
pubmed:meshHeading |
pubmed-meshheading:20498405-Adolescent,
pubmed-meshheading:20498405-Adult,
pubmed-meshheading:20498405-Busulfan,
pubmed-meshheading:20498405-Drug Therapy, Combination,
pubmed-meshheading:20498405-Feasibility Studies,
pubmed-meshheading:20498405-Female,
pubmed-meshheading:20498405-Hematologic Neoplasms,
pubmed-meshheading:20498405-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:20498405-Humans,
pubmed-meshheading:20498405-Male,
pubmed-meshheading:20498405-Middle Aged,
pubmed-meshheading:20498405-Transplantation, Homologous,
pubmed-meshheading:20498405-Transplantation Conditioning,
pubmed-meshheading:20498405-Vidarabine
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning.
|
|
pubmed:affiliation |
University of Rostock, Rostock, Germany. casper.jochen@klinikum-oldenburg.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Evaluation Studies
|
